Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 395

1.

[Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].

Hasselmann C, Bonnemaison E, Faure N, Mercat I, Bouillo Pépin-Donat M, Magontier N, Chantepie A, Labarthe F.

Arch Pediatr. 2012 Jun;19(6):593-8. doi: 10.1016/j.arcped.2012.03.051. Epub 2012 May 14. French.

PMID:
22584198
2.
3.
4.

Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.

Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, Vogel C, Rosenbauer J, Holl RW; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy.

Diabet Med. 2008 Jan;25(1):80-5. doi: 10.1111/j.1464-5491.2007.02311.x.

PMID:
18199134
5.

Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.

Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J.

Pediatr Diabetes. 2008 Oct;9(5):472-9. doi: 10.1111/j.1399-5448.2008.00390.x. Epub 2008 Aug 20.

PMID:
18721168
7.

Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.

Fendler W, Baranowska AI, Mianowska B, Szadkowska A, Mlynarski W.

Acta Diabetol. 2012 Oct;49(5):363-70. doi: 10.1007/s00592-011-0332-7. Epub 2011 Oct 1.

8.
9.
10.

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.

Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M.

Pediatrics. 2003 Sep;112(3 Pt 1):559-64.

PMID:
12949284
11.

Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.

Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M.

Exp Clin Endocrinol Diabetes. 2009 Sep;117(8):378-85. doi: 10.1055/s-0029-1225337. Epub 2009 Jul 23.

PMID:
19629931
12.

Long-term use of continuous subcutaneous insulin infusion compared with multiple daily injections of glargine in pediatric patients.

García-García E, Galera R, Aguilera P, Cara G, Bonillo A.

J Pediatr Endocrinol Metab. 2007 Jan;20(1):37-40.

PMID:
17315527
13.

Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service.

Giménez M, Conget I, Jansà M, Vidal M, Chiganer G, Levy I.

Diabet Med. 2007 Dec;24(12):1419-23. Epub 2007 Oct 17.

PMID:
17941861
14.

Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment?

Sulmont V, Souchon PF, Gouillard-Darnaud C, Fartura A, Salmon-Musial AS, Lambrecht E, Mauran P, Abely M.

J Pediatr. 2010 Jul;157(1):103-7. doi: 10.1016/j.jpeds.2009.12.034. Epub 2010 Mar 15.

PMID:
20227730
15.
16.

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

Diabetes Care. 2004 Jul;27(7):1554-8.

PMID:
15220227
17.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
18.
19.

Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.

Levy-Shraga Y, Lerner-Geva L, Modan-Moses D, Graph-Barel C, Mazor-Aronovitch K, Boyko V, Pinhas-Hamiel O.

Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):225-9. doi: 10.1055/s-0032-1331698. Epub 2013 Jan 17.

PMID:
23329580
20.

A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

Diabetes Care. 2005 Jul;28(7):1568-73.

PMID:
15983302

Supplemental Content

Support Center